jueves, 8 de septiembre de 2016

NCTR Publications > NCTR Research Highlights

NCTR Publications > NCTR Research Highlights

National Center for Toxicological Researh log with FDA on left side

Current Highlight from September 2, 2016

FDA Commissioner Visits NCTR 

On August 31, NCTR hosted FDA Commissioner, Dr. Robert M. Califf. During his visit, Dr. Califf, NCTR Director Dr. William Slikker, Jr. and Arkansas Governor Asa Hutchinson met at the Arkansas State Capitol to renew the Memorandum of Understanding (MOU)disclaimer icon between the FDA, NCTR, and the State of Arkansas. The MOU, the first of its kind, sets general guidelines for the FDA and the State of Arkansas to discuss topics of mutual benefit.
Following the MOU signing, Dr. Califf toured NCTR and FDA’s Office of Regulatory Affairs’ Arkansas Regional Laboratory on the Jefferson Laboratories Campus and visited with staff. Dr. Califf was accompanied by representative product reviewers and administrators from FDA’s Center for Drug Evaluation and Research, Center for Devices and Radiological Health, and Center for Biologics Evaluation and Research. Discussions centered on 1) identifying mechanisms for improving communication and collaboration between the Centers, 2) identifying critical questions of mutual concern to foster scientific research, and 3) the potential to cooperate on continued education of the respective staffs
For more information about the MOU signing, read “Governor, FDA Sign Agreement Extending NCTR Program disclaimer icon” or contact William Slikker, Jr., Ph.D., Director, FDA/NCTR. 

Bacterial Populations Associated with Smokeless Tobacco Products
Scientists from NCTR and FDA’s Center for Tobacco Products completed a microbiological characterization study of 15 common smokeless tobacco products (STPs) and identified several bacterial species capable of reducing nitrates to nitrites, which could lead to the formation of carcinogenic tobacco-specific nitrosamines. The results of this study provide a microbiological baseline for some STPs and provide information that may inform regulatory activities related to STPs. A manuscript detailing this study is available online at Applied and Environmental Microbiologydisclaimer icon.
For additional information, please contact Steve Foley, Ph.D., Division of Microbiology, FDA/NCTR. 

Contact FDA

National Center for Toxicological Research
Food and Drug Administration
3900 NCTR Road
Jefferson, AR 72079

No hay comentarios:

Publicar un comentario